Abstract | INTRODUCTION: METHODS: This study included patients with TSC and epilepsy from fifteen clinics in the United States and one in Belgium who were enrolled in the TSC Natural History Database (2006-2014). Patient demographics and epilepsy treatment patterns, including the use of anti-epileptic drugs (AEDs), epilepsy surgeries, and dietary therapies were assessed. RESULTS: Of the 1328 patients with TSC in the database, 1110 (83.6%) were diagnosed with epilepsy. The median age of epilepsy diagnosis was 0.7 years. Of those who received treatment for epilepsy (92.3%), 99.5% were prescribed AEDs, 25.3% underwent surgery, 7.9% were prescribed special diets, and 1% were prescribed mammalian target of rapamycin ( mTOR) inhibitors. Of the patients receiving AEDs, over half (64.5%) used ≥3 different AEDs, and 22.5% underwent surgical treatment following AED initiation. Of the patients who underwent surgery, 35.1% had subsequent surgery. CONCLUSION: The use of multiple AEDs and surgical interventions may indicate a need for new therapies to reduce the treatment burden among patients with TSC and epilepsy.
|
Authors | Jinlin Song, Elyse Swallow, Qayyim Said, Miranda Peeples, Mark Meiselbach, James Signorovitch, Michael Kohrman, Bruce Korf, Darcy Krueger, Michael Wong, Steven Sparagana |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 391
Pg. 104-108
(08 15 2018)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 30103955
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018. Published by Elsevier B.V. |
Chemical References |
|
Topics |
- Adolescent
- Anticonvulsants
(therapeutic use)
- Child
- Child, Preschool
- Diet Therapy
(trends)
- Epilepsy
(complications, epidemiology, genetics, therapy)
- Female
- Follow-Up Studies
- Humans
- Male
- Neurosurgical Procedures
(trends)
- Retrospective Studies
- Treatment Outcome
- Tuberous Sclerosis
(complications, epidemiology, genetics, therapy)
- Young Adult
|